Skip to content
Tech News
← Back to articles

Samsung is using Galaxy Watch 8 to study what Ozempic, other GLP-1 drugs might secretly do to you

read original more articles
Why This Matters

Samsung's collaboration with Massachusetts General Hospital to study the effects of GLP-1 drugs like Ozempic using Galaxy Watch 8 highlights the growing role of wearable technology in medical research and personalized healthcare. This initiative aims to better understand side effects such as muscle loss, ultimately improving patient safety and treatment outcomes. It underscores the increasing integration of consumer devices into clinical studies, benefiting both the tech industry and consumers seeking safer health management tools.

Key Takeaways

Tushar Mehta / Android Authority

TL;DR Samsung is partnering with the Massachusetts General Hospital (MGH) to investigate the effects of Ozempic and other GLP-1 RA drugs.

Researchers will use body composition and other features of the Galaxy Watch 8 to study trends in rapid muscle loss during treatment.

The control group will also receive personalized health insights for controlled weight loss.

The Samsung Galaxy Watch offers a wider range of health metrics than most rivals in the Wear OS space. That’s one of the reasons why I also prefer the Galaxy Watch over the Pixel Watch. And Samsung now plans to use those markers to help prevent side effects in patients using Ozempic and other GLP-1 RA medications for weight loss.

Don’t want to miss the best from Android Authority? Set us as a favorite source in Google Discover to never miss our latest exclusive reports, expert analysis, and much more.

to never miss our latest exclusive reports, expert analysis, and much more. You can also set us as a preferred source in Google Search by clicking the button below.

Samsung has announced a joint research with the Diabetes Research Center (DRC) at the Massachusetts General Hospital (MGH) to study weight loss trends with GLP-1 RA medications. While Samsung does not explicitly mention popular brand names, potentially to avoid legal issues, some of the popular ones include Ozempic and Mounjaro.

Although the GLP-1 RA class of drugs was primarily designed to help lower blood sugar in Type-2 diabetes, they’ve rapidly gained prominence across the world as effective treatments for obesity and aiding with weight loss without much physical activity, which are actually their side effects. However, since GLP-1 also leads to patients losing their appetite, it can often lead to sudden muscle loss, which can not only impact strength and mobility but also impair internal organs, including the heart, kidneys, liver, etc.

The clinical study, as per Samsung, will track rapid muscle mass loss among patients using GLP-1 drugs using the Galaxy Watch. It says the clinicians will closely monitor trends of body composition, which can be measured with Galaxy Watch 4 and later, along with the patient’s activity levels, to prevent excessive muscle loss during their weight loss treatment.

... continue reading